Acute kidney injury and long-term renal effects of alectinib in anaplastic lymphoma kinase-positive non-small cell lung carcinoma: a case report
ConclusionsOur data suggest direct or indirect toxic (proximal) tubulopathy due to alectinib with a good prognosis after cessation. Adverse acute renal effects of alectinib may be prevented by avoiding other medication influencing renal hemodynamics, in particular nonsteroidal anti-inflammatory drugs. Without these co-medications, alectinib could be reintroduced in our patient.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Aleve | Cancer & Oncology | Carcinoma | Emergency Medicine | Enalapril | Epithelial Cancer | Fortamet | General Medicine | Genetics | Lymphoma | Metformin | Naproxen | Non-Small Cell Lung Cancer | Sodium | Toxicology | Urology & Nephrology